Cite

HARVARD Citation

    Lau, C. et al. (2021). Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework. Vaccine. 39 (51), pp. 7429-7440. [Online]. 
  
Back to record